Victor Mangas Sanjuan (Víctor Mangas-Sanjuán, Victor Mangas-Sanjuán, Víctor Mangas-Sanjuan, Victor Mangas-Sanjuan)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 27

Top Venues

Pharmaceutics

British journal of clinical pharmacology

Cancers

Universidad de Valencia

University of Valencia (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Universidad de Valencia Apr 10 2017

Spain

Ayudante doctor :: Farmacia y Tecnologia Farmaceutica

Education History

University of Valencia

Spain

PHD

University of Valencia

Spain

MSC

Publications

Andreu Mañez-Asensi, Mª Jesús Hernández, Victor Mangas Sanjuan, Ana Salvador, Matilde Merino-Sanjuán, Virginia Merino
Impact of Time on Parameters for Assessing the Microstructure Equivalence of Topical Products: Diclofenac 1% Emulsion as a Case Study. Pharmaceutics 16 (6) (2024)
Gloria M Alfosea-Cuadrado, Javier Zarzoso-Foj, Albert Adell, Alfonso A Valverde-Navarro, Eva M González-Soler, Victor Mangas Sanjuan, Arantxa Blasco-Serra
Population Pharmacokinetic-Pharmacodynamic Analysis of a Reserpine-Induced Myalgia Model in Rats. Pharmaceutics 16 (8) (2024)
Andreu Mañez-Asensi, Mª Jesús Hernández, Victor Mangas Sanjuan, Ana Salvador, Matilde Merino-Sanjuán, Virginia Merino
Impact of Time on Parameters for Assessing the Microstructure Equivalence of Topical Products: Diclofenac 1% Emulsion as a Case Study. Pharmaceutics 16 (6) (2024)
Gloria M Alfosea-Cuadrado, Javier Zarzoso-Foj, Albert Adell, Alfonso A Valverde-Navarro, Eva M González-Soler, Victor Mangas Sanjuan, Arantxa Blasco-Serra
Population Pharmacokinetic-Pharmacodynamic Analysis of a Reserpine-Induced Myalgia Model in Rats. Pharmaceutics 16 (8) (2024)
Alfredo Garcia-Arieta, John Gordon, Luther Gwaza, Virginia Merino, Victor Mangas Sanjuan
Regulatory Requirements for the Development of Second-Entry Semisolid Topical Products in the European Union. Pharmaceutics 15 (2) (2023)
Alfredo Garcia-Arieta, John Gordon, Luther Gwaza, Virginia Merino, Victor Mangas Sanjuan
Regulatory Requirements for the Development of Second-Entry Semisolid Topical Products in the European Union. Pharmaceutics 15 (2) (2023)
Victor Mangas Sanjuan, Marta Simón, Esperanza González-Rojano, Dolores Ochoa, Francisco Abad-Santos, Manuel Román, Mercedes Ramos, Carlos Govantes, Alfredo Garcia-Arieta
Alternative Pharmacokinetic Metrics in Single-Dose Studies to Ensure Bioequivalence of Prolonged-Release Products at Steady State-A Case Study. Pharmaceutics 15 (2) (2023)
Alfredo Garcia-Arieta, John Gordon, Luther Gwaza, Virginia Merino, Victor Mangas Sanjuan
Regulatory Requirements for the Development of Second-Entry Semisolid Topical Products in the European Union. Pharmaceutics 15 (2) (2023)
Javier Reig-Lopez, Weifeng Tang, Carlos Fernandez-Teruel, Matilde Merino-Sanjuan, Victor Mangas Sanjuan, David W Boulton, Pradeep Sharma
Application of population physiologically based pharmacokinetic modelling to optimize target expression and clearance mechanisms of therapeutic monoclonal antibodies. British journal of clinical pharmacology (2023)
Victor Mangas Sanjuan, Marta Simón, Esperanza González-Rojano, Dolores Ochoa, Francisco Abad-Santos, Manuel Román, Mercedes Ramos, Carlos Govantes, Alfredo Garcia-Arieta
Alternative Pharmacokinetic Metrics in Single-Dose Studies to Ensure Bioequivalence of Prolonged-Release Products at Steady State-A Case Study. Pharmaceutics 15 (2) (2023)
Alfredo Garcia-Arieta, John Gordon, Luther Gwaza, Virginia Merino, Victor Mangas Sanjuan
Regulatory Requirements for the Development of Second-Entry Semisolid Topical Products in the European Union. Pharmaceutics 15 (2) (2023)
Alfredo Garcia-Arieta, John Gordon, Luther Gwaza, Virginia Merino, Victor Mangas Sanjuan
Regulatory Requirements for the Development of Second-Entry Semisolid Topical Products in the European Union. Pharmaceutics 15 (2) (2023)
Victor Mangas Sanjuan, Marta Simón, Esperanza González-Rojano, Dolores Ochoa, Francisco Abad-Santos, Manuel Román, Mercedes Ramos, Carlos Govantes, Alfredo Garcia-Arieta
Alternative Pharmacokinetic Metrics in Single-Dose Studies to Ensure Bioequivalence of Prolonged-Release Products at Steady State-A Case Study. Pharmaceutics 15 (2) (2023)
Mark McAllister, Talia Flanagan, Susan Cole, Andreas Abend, Evangelos Kotzagiorgis, Jobst Limberg, Heather Mead, Victor Mangas Sanjuan, Paul A Dickinson, Andrea Moir, Xavier Pepin, Diansong Zhou, Christophe Tistaert, Aristides Dokoumetzidis, Om Anand, Maxime Le Merdy, David B Turner, Brendan T Griffin, Adam Darwich, Jennifer Dressman, Claire Mackie
Developing Clinically Relevant Dissolution Specifications (CRDSs) for Oral Drug Products: Virtual Webinar Series. Pharmaceutics 14 (5) (2022)
Teresa García-Martínez, María Dolores Bellés-Medall, Maria Garcia-Cremades, Raúl Ferrando-Piqueres, Victor Mangas Sanjuan, Matilde Merino-Sanjuán
Population Pharmacokinetic/Pharmacodynamic Modelling of Daptomycin for Schedule Optimization in Patients with Renal Impairment. Pharmaceutics 14 (10) (2022)
Elena Gras-Colomer, Victor Mangas Sanjuan, María-Amparo Martínez-Gómez, Mónica Climente-Martí, Matilde Merino-Sanjuan
Quantitative assessment of the exposure-efficacy relationship of glucocerebrosidase using Markovian elements in Gaucher patients treated with enzyme replacement therapy. British journal of clinical pharmacology 88 (6) (2022)
Karine Rodríguez-Fernández, Victor Mangas Sanjuan, Matilde Merino-Sanjuán, Antonio Martorell-Calatayud, Almudena Mateu-Puchades, Mónica Climente-Martí, Elena Gras-Colomer
Impact of Pharmacokinetic and Pharmacodynamic Properties of Monoclonal Antibodies in the Management of Psoriasis. Pharmaceutics 14 (3) (2022)
Francisco José Toja-Camba, Nerea Gesto-Antelo, Olalla Maroñas, Eduardo Echarri Arrieta, Irene Zarra-Ferro, Miguel González-Barcia, Enrique José Bandín-Vilar, Victor Mangas Sanjuan, Fernando Facal, Manuel Arrojo Romero, Angel Carracedo, Cristina Mondelo-García, Anxo Fernandez-Ferreiro
Review of Pharmacokinetics and Pharmacogenetics in Atypical Long-Acting Injectable Antipsychotics. Pharmaceutics 13 (7) (2021)
Aymara Sancho-Araiz, Sara Zalba, María J Garrido, Pedro Berraondo, Brian Topp, Dinesh de Alwis, Zinnia P Parra-Guillen, Victor Mangas Sanjuan, Iñaki F Trocóniz
Semi-Mechanistic Model for the Antitumor Response of a Combination Cocktail of Immuno-Modulators in Non-Inflamed (Cold) Tumors. Cancers 13 (20) (2021)
Javier Reig-López, Alfredo Garcia-Arieta, Victor Mangas Sanjuan, Matilde Merino-Sanjuán
Current Evidence, Challenges, and Opportunities of Physiologically Based Pharmacokinetic Models of Atorvastatin for Decision Making. Pharmaceutics 13 (5) (2021)
Aymara Sancho-Araiz, Victor Mangas Sanjuan, Iñaki F Trocóniz
The Role of Mathematical Models in Immuno-Oncology: Challenges and Future Perspectives. Pharmaceutics 13 (7) (2021)
Javier Reig-López, María Del Mar Maldonado, Matilde Merino-Sanjuán, Ailed M Cruz-Collazo, Jean F Ruiz-Calderón, Victor Mangas Sanjuan, Suranganie Dharmawardhane, Jorge Duconge
Physiologically-Based Pharmacokinetic/Pharmacodynamic Model of MBQ-167 to Predict Tumor Growth Inhibition in Mice. Pharmaceutics 12 (10) (2020)
Marina Sáez-Belló, Victor Mangas Sanjuan, Mª Amparo Martínez-Gómez, Mª Ángeles López-Montenegro Soria, Mónica Climente-Martí, Matilde Merino-Sanjuán
Evaluation of ABC gene polymorphisms on the pharmacokinetics and pharmacodynamics of capecitabine in colorectal patients: Implications for dosing recommendations. British journal of clinical pharmacology 87 (3) (2020)
Niurys de Castro-Suárez, Mirjam N Trame, Mayra Ramos-Suzarte, José M Dávalos, Raymed A Bacallao-Mendez, Anaelys R Maceo-Sinabele, Victor Mangas Sanjuan, Gledys Reynaldo-Fernández, Leyanis Rodríguez-Vera
Semi-Mechanistic Pharmacokinetic Model to Guide the Dose Selection of Nimotuzumab in Patients with Autosomal Dominant Polycystic Kidney Disease. Pharmaceutics 12 (12) (2020)
Darlene Santiago, Victor Mangas Sanjuan, Kyle R Melin, Jorge Duconge, Wenchen Zhao, Raman Venkataramanan
Pharmacokinetic Characterization and External Evaluation of a Quantitative Framework of Sublingual Buprenorphine in Patients with an Opioid Disorder in Puerto Rico. Pharmaceutics 12 (12) (2020)
Zhengguo Xu, Victor Mangas Sanjuan, Matilde Merino-Sanjuán, Virginia Merino, Alfredo Garcia-Arieta
Influence of Inter- and Intra-Batch Variability on the Sample Size Required for Demonstration of Equivalent Microstructure of Semisolid Dosage Forms. Pharmaceutics 12 (12) (2020)
Laura García-Quintanilla, Andrea Luaces-Rodríguez, María Gil-Martínez, Cristina Mondelo-García, Olalla Maroñas, Victor Mangas Sanjuan, Miguel González-Barcia, Irene Zarra-Ferro, Pablo Aguiar, Francisco-Javier Otero-Espinar, Anxo Fernandez-Ferreiro
Pharmacokinetics of Intravitreal Anti-VEGF Drugs in Age-Related Macular Degeneration. Pharmaceutics 11 (8) (2019)

Victor Mangas Sanjuan.css-eqlu8i{font-size:small;padding-left:4px;} (Víctor Mangas-Sanjuán, Victor Mangas-Sanjuán, Víctor Mangas-Sanjuan, Victor Mangas-Sanjuan)

Publication Activity (10 Years)

Top Topics

Top Venues

Victor Mangas Sanjuan (Víctor Mangas-Sanjuán, Victor Mangas-Sanjuán, Víctor Mangas-Sanjuan, Victor Mangas-Sanjuan)